| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $330.5M | +21.6% |
| Cost of Revenue | $82.5M | +6.5% |
| Gross Profit | $248.0M | +27.6% |
| R&D Expense | $48.7M | +34.0% |
| SG&A Expense | $69.2M | +13.0% |
| Operating Income | $7.2M | +146.7% |
| Pre-tax Income | -$24.4M | -31.1% |
| Income Tax | $4.7M | +64.3% |
| Net Income | -$29.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $290.7M | +30.3% |
| Short-term Investments | $167K | -95.5% |
| Accounts Receivable | $87.4M | +1.7% |
| Current Assets | $394.8M | +21.3% |
| Total Assets | $519.1M | +17.3% |
| Current Liabilities | $223.0M | +26.2% |
| Total Liabilities | $248.1M | +13.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $88.9M | +156.2% |
| Capital Expenditures | $3.0M | +45.9% |
| Investing Cash Flow | -$2.6M | +53.9% |
| Financing Cash Flow | -$15.5M | +53.9% |
| Free Cash Flow | $85.8M | +163.3% |
| -34.1% |
| EPS (Basic) | -$0.16 | -33.3% |
| Stockholders' Equity |
| $229.1M |
| +4.7% |